Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01989923 · ClinicalTrials.gov registry record · NA
Smoking Cessation in Women With Gynecological Conditions
A NA study of Cervical Dysplasia, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT01989923: Completed NA study of Cervical Dysplasia, sponsored by University of Oklahoma.
NCT01989923 is a NA study of Cervical Dysplasia that has completed, run by University of Oklahoma. The registered enrollment target is 31 participants, below the 545-participant average among 7 other Cervical Dysplasia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01989923, a NA study of Cervical Dysplasia, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
This feasibility study will compare two smoking cessation methods, traditional nicotine replacement therapy and Electronic Nicotine Delivery Systems (electronic cigarettes) in patients with gynecological conditions.
Primary Outcome
To determine the acceptability of traditional nicotine replacement therapy (nicotine patch plus nicotine gum or lozenges) and the ENDS (electronic nicotine delivery system or electronic cigarette as smoking cessation tools in a group of women with cervical dysplasia from the Stephenson Cancer Center Dysplasia Clinics. Measurements to assess success: 1. Reduction of number of cigarettes smoked per day. 2. Point prevalence abstinence at 7 and 30 days 3. Smoking cessation rates 4. Qualitative int
Conditions Studied
Interventions
- OTHER Nicotine Replacement Therapy
- DEVICE Electronic Cigarettes
Study Locations (1)
Oklahoma
- Stephenson Cancer Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-04-13 |
| Phase | NA |
What the finished NCT01989923 record still lists
NCT01989923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 545-participant average among 7 other Cervical Dysplasia trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cervical Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Nicotine Replacement Therapy is the first listed.
NCT01989923 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01989923 about?
NCT01989923 is a clinical study titled "Smoking Cessation in Women With Gynecological Conditions". This feasibility study will compare two smoking cessation methods, traditional nicotine replacement therapy and Electronic Nicotine Delivery Systems (electronic cigarettes) in patients with gynecological conditions.
What is the current status of trial NCT01989923?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2013-06. Estimated completion is 2017-04-13.
What conditions does trial NCT01989923 study?
This clinical trial studies the following conditions: Cervical Dysplasia.
What interventions are being tested in trial NCT01989923?
The interventions under investigation include: Nicotine Replacement Therapy (OTHER), Electronic Cigarettes (DEVICE).
Who is sponsoring clinical trial NCT01989923?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01989923 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
RECRUITING · NA
-
Coherence Imaging of the Cervical Epithelium With Scanning a/LCI
COMPLETED · NA
-
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RECRUITING
-
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
RECRUITING · Phase 2
-
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
COMPLETED · Phase 3
-
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia